ENTITY
Dechra Pharmaceuticals

Dechra Pharmaceuticals (DPH LN)

44
Analysis
Health Care • United Kingdom
Dechra Pharmaceuticals is a global specialist in the development, manufacture, and marketing of high-quality veterinary pharmaceuticals and related products, focusing on companion animals, equine, and food-producing animals. Key products include treatments for endocrinology, dermatology, and pain management, such as Vetoryl for Cushing's disease in dogs and Felimazole for hyperthyroidism in cats. The company was founded in 1997 and moved its global headquarters to Boston, Massachusetts, in June 2026.
more
Company Event • 26 Feb 2024 18:30 • Upcoming
Add To Calendar

H1 2024

Company Event • 12 Oct 2023 14:00 • Upcoming
Add To Calendar

H2 2023

Company Event • 22 May 2023 14:00 • Upcoming
Add To Calendar

Trading Update

Company Event • 27 Feb 2023 18:30 • Latest

H1 2023

Company Event • 12 Jan 2023 16:00 • Upcoming
Add To Calendar

Trading Update

x